JP2021102644A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021102644A5 JP2021102644A5 JP2021054632A JP2021054632A JP2021102644A5 JP 2021102644 A5 JP2021102644 A5 JP 2021102644A5 JP 2021054632 A JP2021054632 A JP 2021054632A JP 2021054632 A JP2021054632 A JP 2021054632A JP 2021102644 A5 JP2021102644 A5 JP 2021102644A5
- Authority
- JP
- Japan
- Prior art keywords
- amount
- pharmaceutical composition
- serum
- per unit
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022175999A JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361789777P | 2013-03-15 | 2013-03-15 | |
| US61/789,777 | 2013-03-15 | ||
| JP2019172758A JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019172758A Division JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022175999A Division JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021102644A JP2021102644A (ja) | 2021-07-15 |
| JP2021102644A5 true JP2021102644A5 (https=) | 2021-09-02 |
Family
ID=50336511
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500381A Pending JP2016517408A (ja) | 2013-03-15 | 2014-02-25 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2019172758A Pending JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2021054632A Pending JP2021102644A (ja) | 2013-03-15 | 2021-03-29 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2022175999A Withdrawn JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016500381A Pending JP2016517408A (ja) | 2013-03-15 | 2014-02-25 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
| JP2019172758A Pending JP2020063237A (ja) | 2013-03-15 | 2019-09-24 | 抗ｉｌ−２３抗体を用いた乾癬の治療方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022175999A Withdrawn JP2023011815A (ja) | 2013-03-15 | 2022-11-02 | 抗ｉｌ－２３抗体を用いた乾癬の治療方法 |
Country Status (17)
| Country | Link |
|---|---|
| US (3) | US20160060337A1 (https=) |
| EP (2) | EP3689369A1 (https=) |
| JP (4) | JP2016517408A (https=) |
| KR (1) | KR20150128858A (https=) |
| CN (1) | CN105209064A (https=) |
| AP (1) | AP2015008803A0 (https=) |
| AU (3) | AU2014238148A1 (https=) |
| CA (1) | CA2906382A1 (https=) |
| CL (1) | CL2015002723A1 (https=) |
| CR (1) | CR20150572A (https=) |
| EA (1) | EA201591581A1 (https=) |
| HK (1) | HK1219425A1 (https=) |
| IL (2) | IL241342A0 (https=) |
| PH (2) | PH12015502129A1 (https=) |
| SG (2) | SG11201507482UA (https=) |
| TN (1) | TN2015000403A1 (https=) |
| WO (1) | WO2014149425A1 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2019000046A (es) | 2010-11-04 | 2023-10-05 | Boehringer Ingelheim Int | Anticuerpos anti-il-23. |
| PL3326649T3 (pl) | 2012-05-03 | 2022-04-25 | Boehringer Ingelheim International Gmbh | Przeciwciała anty-il-23p19 |
| EP3708679A1 (en) | 2014-07-24 | 2020-09-16 | Boehringer Ingelheim International GmbH | Biomarkers useful in the treatment of il-23a related diseases |
| EA202193002A2 (ru) | 2014-09-03 | 2022-03-31 | Бёрингер Ингельхайм Интернациональ Гмбх | Соединение, нацеленное на ил-23a и фно-альфа, и его применение |
| AU2016215535B2 (en) * | 2015-02-04 | 2021-09-16 | Boehringer Ingelheim International Gmbh | Methods of treating inflammatory diseases |
| CN109071653A (zh) * | 2016-03-29 | 2018-12-21 | 詹森生物科技公司 | 用增加的抗-il12和/或-23抗体给药间隔治疗牛皮癣 |
| JP6728392B2 (ja) * | 2016-04-15 | 2020-07-22 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 炎症性疾患の処置法 |
| US20200025776A1 (en) * | 2018-07-18 | 2020-01-23 | Janssen Biotech, Inc. | Sustained Response Predictors After Treatment With Anti-IL23 Specific Antibody |
| CA3118964A1 (en) * | 2018-11-05 | 2020-05-14 | Merck Sharp & Dohme Corp. | Dosing regimen of anti-tigit antibody for treatment of cancer |
| JP2022526493A (ja) * | 2019-03-18 | 2022-05-25 | ヤンセン バイオテツク，インコーポレーテツド | 抗ｉｌ１２／ｉｌ２３抗体を用いた小児被験者の乾癬の治療方法 |
| TW202535466A (zh) | 2019-09-09 | 2025-09-16 | 德商百靈佳殷格翰國際股份有限公司 | 抗-il-23p19抗體調配物 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6171586B1 (en) | 1997-06-13 | 2001-01-09 | Genentech, Inc. | Antibody formulation |
| ZA986596B (en) | 1997-07-25 | 1999-02-08 | Schering Corp | Mammalian cytokine related reagents |
| SI2452694T1 (sl) | 2005-06-30 | 2019-05-31 | Janssen Biotech, Inc. | Protitelesa proti-IL-23, sestavki in postopki uporabe |
| DE602006015830D1 (de) | 2005-08-25 | 2010-09-09 | Lilly Co Eli | Anti-il-23-antikörper |
| US20070050011A1 (en) | 2005-08-26 | 2007-03-01 | Medlogics Device Corporation | Lumen-supporting stents and methods for creating lumen-supporting stents with various open/closed designs |
| PT1931710T (pt) | 2005-08-31 | 2017-03-28 | Merck Sharp & Dohme | Anticorpos anti-il-23 manipulados |
| CN101389769A (zh) * | 2005-12-28 | 2009-03-18 | 森托科尔公司 | 用于评价和治疗银屑病及相关疾病的标记与方法 |
| HUE034269T2 (en) | 2005-12-29 | 2018-02-28 | Janssen Biotech Inc | Human anti-IL-23 antibodies, preparations, methods and applications |
| US7790862B2 (en) | 2006-06-13 | 2010-09-07 | Zymogenetics, Inc. | IL-17 and IL-23 antagonists and methods of using the same |
| JP2010518858A (ja) | 2007-02-23 | 2010-06-03 | シェーリング コーポレイション | 操作された抗−ｉｌ−２３ｐ１９抗体 |
| ES2708988T3 (es) | 2007-02-23 | 2019-04-12 | Merck Sharp & Dohme | Anticuerpos anti-IL-23p19 obtenidos por ingeniería genética |
| AR068723A1 (es) | 2007-10-05 | 2009-12-02 | Glaxo Group Ltd | Proteina que se une a antigenos que se une a il-23 humana y sus usos |
| WO2009082624A2 (en) | 2007-12-10 | 2009-07-02 | Zymogenetics, Inc. | Antagonists of il-17a, il-17f, and il-23 and methods of using the same |
| WO2009117289A2 (en) * | 2008-03-18 | 2009-09-24 | Abbott Laboratories | Methods for treating psoriasis |
| EP2301119B1 (en) | 2008-06-30 | 2015-05-13 | Black & Decker, Inc. | Cord protector for power tools |
| EP2331078B1 (en) | 2008-08-27 | 2012-09-19 | Merck Sharp & Dohme Corp. | Lyophilized formulations of engineered anti-il-23p19 antibodies |
| US20120128689A1 (en) | 2009-04-01 | 2012-05-24 | Glaxo Group Limited | Anti-il-23 immunoglobulins |
| US20120264917A1 (en) | 2009-05-27 | 2012-10-18 | Ablynx N.V. | Biparatopic protein constructs directed against il-23 |
| SG179135A1 (en) * | 2009-09-14 | 2012-05-30 | Abbott Lab | Methods for treating psoriasis |
| JO3244B1 (ar) | 2009-10-26 | 2018-03-08 | Amgen Inc | بروتينات ربط مستضادات il – 23 البشرية |
| PH12012501364A1 (en) | 2010-01-15 | 2012-10-22 | Amgen K A Inc | Antibody formulation and therapeutic regimens |
| WO2012009760A1 (en) | 2010-07-20 | 2012-01-26 | Cephalon Australia Pty Ltd | Anti-il-23 heterodimer specific antibodies |
| CN103813804A (zh) * | 2010-10-06 | 2014-05-21 | Abbvie公司 | 用于治疗银屑病的方法 |
| CN103154031A (zh) * | 2010-10-08 | 2013-06-12 | 诺华有限公司 | 利用il-17拮抗剂治疗牛皮癣的方法 |
| MX2019000046A (es) | 2010-11-04 | 2023-10-05 | Boehringer Ingelheim Int | Anticuerpos anti-il-23. |
-
2014
- 2014-02-25 SG SG11201507482UA patent/SG11201507482UA/en unknown
- 2014-02-25 CN CN201480015797.0A patent/CN105209064A/zh active Pending
- 2014-02-25 EA EA201591581A patent/EA201591581A1/ru unknown
- 2014-02-25 SG SG10201804954UA patent/SG10201804954UA/en unknown
- 2014-02-25 HK HK16107479.7A patent/HK1219425A1/zh unknown
- 2014-02-25 AU AU2014238148A patent/AU2014238148A1/en not_active Abandoned
- 2014-02-25 EP EP19206477.2A patent/EP3689369A1/en not_active Withdrawn
- 2014-02-25 CA CA2906382A patent/CA2906382A1/en not_active Abandoned
- 2014-02-25 WO PCT/US2014/018293 patent/WO2014149425A1/en not_active Ceased
- 2014-02-25 JP JP2016500381A patent/JP2016517408A/ja active Pending
- 2014-02-25 US US14/776,222 patent/US20160060337A1/en not_active Abandoned
- 2014-02-25 EP EP14711352.6A patent/EP2968488A1/en not_active Withdrawn
- 2014-02-25 KR KR1020157027833A patent/KR20150128858A/ko not_active Ceased
- 2014-02-25 AP AP2015008803A patent/AP2015008803A0/xx unknown
-
2015
- 2015-09-09 IL IL241342A patent/IL241342A0/en unknown
- 2015-09-09 TN TN2015000403A patent/TN2015000403A1/en unknown
- 2015-09-15 CL CL2015002723A patent/CL2015002723A1/es unknown
- 2015-09-15 PH PH12015502129A patent/PH12015502129A1/en unknown
- 2015-10-15 CR CR20150572A patent/CR20150572A/es unknown
-
2019
- 2019-01-11 AU AU2019200206A patent/AU2019200206A1/en not_active Abandoned
- 2019-09-24 JP JP2019172758A patent/JP2020063237A/ja active Pending
- 2019-10-10 US US16/598,714 patent/US20200277368A1/en not_active Abandoned
- 2019-11-28 PH PH12019502700A patent/PH12019502700A1/en unknown
-
2020
- 2020-06-03 IL IL275093A patent/IL275093A/en unknown
- 2020-11-18 AU AU2020270495A patent/AU2020270495A1/en not_active Abandoned
-
2021
- 2021-03-29 JP JP2021054632A patent/JP2021102644A/ja active Pending
-
2022
- 2022-01-13 US US17/574,980 patent/US20220135668A1/en not_active Abandoned
- 2022-11-02 JP JP2022175999A patent/JP2023011815A/ja not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021102644A5 (https=) | ||
| JP5129122B2 (ja) | 癌治療のための抗体およびグルココルチコイドの組み合わせ | |
| AU2014337385B2 (en) | Chimeric antigen receptor T cell switches and uses thereof | |
| JP2023139071A (ja) | Ｉｌ－４ｒ拮抗薬の投与により喘息を処置または予防するための方法 | |
| JP2007515469A5 (https=) | ||
| US20220000872A1 (en) | Method of enhancing immune-based therapy | |
| JP2014114288A5 (https=) | ||
| JP2006527193A5 (https=) | ||
| JP2016509009A (ja) | Ｔ制御性細胞の増殖または枯渇方法 | |
| JP2013543501A5 (https=) | ||
| JP2012510965A (ja) | 結腸癌発生を予防または低減する方法 | |
| TW202106334A (zh) | 藉由投予ｉｌ－３３拮抗劑治療或預防哮喘之方法 | |
| Pitarokoili et al. | Induction of regulatory properties in the intestinal immune system by dimethyl fumarate in Lewis rat experimental autoimmune neuritis | |
| JP2016510766A (ja) | １型糖尿病の処置及び／又は予防のための方法及び組成物 | |
| JP2006514681A5 (https=) | ||
| TW202034950A (zh) | 用於治療b型肝炎的藥物製劑及其製備方法和用途 | |
| WO2021057764A1 (zh) | Pd-1抗体联合紫杉类化合物在制备治疗三阴性乳腺癌的药物中的用途 | |
| CN110859959A (zh) | 抗pd-1抗体联合紫杉醇和铂类化合物在制备治疗食管癌的药物中的用途 | |
| TW202034925A (zh) | Ｃｄｋ４／６抑制劑聯合免疫治療在製備治療淋巴瘤的藥物中的用途 | |
| CN119546337A (zh) | 通过施用il-4r拮抗剂治疗小儿嗜酸性粒细胞性食管炎的方法 | |
| EP4458413A2 (en) | A pharmaceutical composition and the use thereof in the treatment of autoimmune diseases | |
| Stephen et al. | A comparative study of once daily versus twice daily tacrolimus in liver transplantation | |
| WO2008061429A1 (fr) | Procédé d'utilisation de triacontanol visant à préparer des médicaments destinés à traiter des cancers | |
| AU2021104207A4 (en) | Halloysite nanotube as a modified drug release carrier for 6-mercaptopurine | |
| TWI882612B (zh) | 藥物組合及其應用 |